Llwytho...
Effects of Risperidone and Galantamine treatment on Alzheimer biomarker levels in cerebrospinal fluid
BACKGROUND: Treatment for neuropsychiatric symptoms (NPS) in dementia is insufficient. Antipsychotics and acetylcholinesterase inhibitors are used generating symptomatic improvements in behaviour and cognition, but few studies have investigated their effect on Alzheimer biomarkers in cerebrospinal f...
Wedi'i Gadw mewn:
| Cyhoeddwyd yn: | J Alzheimers Dis |
|---|---|
| Prif Awduron: | , , , , , , |
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
2017
|
| Pynciau: | |
| Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6203339/ https://ncbi.nlm.nih.gov/pubmed/28269767 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3233/JAD-160758 |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|